5′-磷酸腺苷对小鼠脾细胞氧化应激损伤的保护作用

目的研究5′-磷酸腺苷（5′-AMP）体外抗氧化和对体外氧化损伤脾细胞的损伤修复能力。方法用化学比色法测定5′-AMP体外清除二苯代苦味酰基自由基（DPPH自由基）的能力;建立过氧化氢（H2O2）氧化损伤体外培养小鼠脾细胞模型,用MTT法检测5′-AMP修复受损伤脾细胞的作用,并分析其对细胞抗氧化体系及抗氧化能力的影响。结果5′-AMP具有剂量依赖性的体外抗氧化和清除活性氧能力,添加0.5mmol/L、1mmol/L、5mmol/L和10mmol/L5′-AMP均能显著修复H2O2诱导的脾细胞氧化损伤（P〈0.05）,总抗氧化能力和抗氧化酶类活力（P〈0.01）,5′-AMP添加量大于1mmol/L时,可显著降低丙二醛（MDA）含量（P〈0.01）。其细胞培养液的氧自由基（ROS）水平逐渐降低,5′-AMP添加量为10mmol/L时,ROS水平接近对照组水平。结论5′-磷酸腺苷能显著修复氧化损伤,具有显著的抗氧化作用。     

胞外三磷酸腺苷对铅胁迫下植物细胞损伤和过氧化氢及其清除酶水平的调节

细胞外三磷酸腺苷（extracellular adenosine-5'-triphosphate）是植物细胞的重要信号分子。以烟草悬浮细胞BY-2（Nicotiana tabacum L.cv.Bright Yellow-2）为材料,探讨了胞外三磷酸腺苷对铅胁迫下细胞损伤、H₂O₂（过氧化氢）含量及H₂O₂清除酶活性的影响。结果显示,随着Pb（NO₃）₂浓度的不断提高（30~400 μmol·L^-1）,细胞外三磷酸腺苷含量呈现出逐渐下降的趋势,但胞内三磷酸腺苷含量及细胞的受损伤程度逐渐增大;同时,H₂O₂含量和过氧化氢酶的活性均有所上升,并在200 μmol·L^-1 Pb（NO₃）₂处理下达到最大值,而过氧化物酶的活性则不断降低。较之Pb（NO₃）₂胁迫下的细胞,对Pb（NO₃）₂胁迫的细胞加入外源三磷酸腺苷使得细胞受损伤程度显著降低,H₂O₂含量减少,过氧化氢酶活性减弱,而过氧化物酶活性增强。实验结果表明,Pb（NO₃）₂胁迫诱导的植物细胞损伤和H₂O₂及其清除酶水平的变化能受到细胞外三磷酸腺苷水平的调节。     

蝉花虫草提取物N~6-(2-羟乙基)腺苷对小鼠肾脏缺血再灌注损伤的保护作用

研究蝉花虫草提取物N~6-(2-羟乙基)腺苷[N~6-(2-hydroxyethyl)-adenosine,HEA]对小鼠肾脏缺血再灌注损伤(ischemia reperfusion,IR)的影响。选择20–25g雄性C57BL/6小鼠,随机分成5组。假手术组小鼠仅接受腹中线开腹、游离双侧肾蒂及缝合腹部操作;IR组小鼠制成肾脏IR模型,不给药;HEA低剂量组、HEA中剂量组、HEA高剂量组分别在建立肾脏缺血再灌注模型前15min腹腔注射HEA(2.5mg/kg、5mg/kg和7.5mg/kg)。再灌注24h后检测各组肾功能指标血清肌酐(serum creatinine,Scr)和尿素氮(blood urea nitrogen,BUN)水平。苏木精-伊红染色后用光学显微镜观察肾脏组织形态学改变。电镜和TUNEL分析法观察肾小管上皮细胞凋亡状况。实时荧光定量RT-PCR检测细胞间粘附分子-1(intercellular adhesion molecule-1,ICAM-1)、白细胞介素(interleukin-1β,IL-1β)和肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)等基因的m RNA的表达情况。结果显示,与假手术组比较,IR组BUN和Scr水平明显升高(P0.01,P0.05);肾脏病理表现为上皮细胞碎片和管型,且最为严重;与IR组比较,HEA 7.5mg/kg组血清BUN和Scr水平显著降低(P0.05);HEA 5mg/kg组和HEA 7.5mg/kg组肾损伤情况明显改善(P0.05,P0.01);电镜观察可知HEA 7.5mg/kg组明显改善肾小管上皮细胞的损伤程度,并且保护线粒体和细胞核膜的完整性。原位末端标记法[terminal dexynucleotidyl transferase(Td T)-mediated d UTP nick end labeling,TUNEL]显示HEA治疗组凋亡细胞数量明显低于IR组(P0.01)。HEA治疗组ICAM-1、IL-1β和TNF-αm RNA的水平均低于IR组(P0.01)。所以预处理HEA 7.5mg/kg对肾脏缺血再灌注有保护作用。     

八种因素对头孢霉菌丝脂肪酸不饱和指数的影响

为了探讨环境胁迫和真菌脂肪酸不饱和度的关系 ,用合成培养基探讨 8种单一因子对头孢霉(Cephalosporiumsp .)菌丝体脂肪酸不饱和指数的影响。结果表明 ,低起始 pH值 (4 .0～ 5 .0 ) ,低培养温度 (10～ 15℃ ) ,有利于获得高不饱和指数 ;随着三角瓶装液量的增加 ,脂肪酸不饱和指数逐步降低 ;接种量对脂肪酸不饱和指数影响不大 ;葡萄糖或蔗糖作为碳源 ,NH4 Cl或 (NH4 ) 2 SO4 作为氮源 ,低碳源浓度 (10～ 2 0g/L)有利于获得高不饱和指数 ;随着培养时间增加 ,脂肪酸不饱和指数逐步增加 ,至 10d时脂肪酸不饱和指数可达最高 ,为 170 .38     

Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue: ROLE OF ILE198

The chemokine receptors CCR5 and CCR2b share 89% amino acid homology. CCR5 is a co-receptor for HIV and CCR5 antagonists have been investigated as inhibitors of HIV infection. We describe the use of two CCR5 antagonists, Schering-C (SCH-C), which is specific for CCR5, and TAK-779, a dual inhibitor of CCR5 and CCR2b, to probe the CCR5 inhibitor binding site using CCR5/CCR2b chimeric receptors. Compound inhibition in the different chimeras was assessed by inhibition of chemokine-induced calcium flux. SCH-C inhibited RANTES (regulated on activation, normal T cell expressed and secreted) (CCL5)-mediated calcium flux on CCR5 with an IC₅₀ of 22.8 nm but was inactive against monocyte chemoattractant protein-1 (CCL2)-mediated calcium flux on CCR2b. However, SCH-C inhibited CCL2-induced calcium flux against a CCR5/CCR2b chimera consisting of transmembrane domains IV–VI of CCR5 with an IC₅₀ of 55 nm. A sequence comparison of CCR5 and CCR2b identified a divergent amino acid sequence located at the junction of transmembrane domain V and second extracellular loop. Transfer of the CCR5 sequence KNFQTLKIV into CCR2b conferred SCH-C inhibition (IC₅₀ of 122 nm) into the predominantly CCR2b chimera. Furthermore, a single substitution, R206I, conferred partial but significant inhibition (IC₅₀ of 1023 nm) by SCH-C. These results show that a limited amino acid sequence is responsible for SCH-C specificity to CCR5, and we propose a model showing the interaction with CCR5 Ile¹⁹⁸.     

Toxoplasma gondii: the enzymic defect of a mutant resistant to 5-fluorodeoxyuridine.

We have previously described a mutant of Toxoplasma gondii that was 100-fold more resistant to 5-fluorodeoxyuridine, as measured by growth in human fibroblast cultures. Various pyrimidine salvage enzymes were measured in the wild type and the mutant parasites to determine the biochemical basis for resistance to fluorodeoxyuridine. Both the resistant mutant and the wild type parasite had little or no uridine kinase, an enzyme readily detectable in the human fibroblast host cells. Uridine and deoxyuridine phosphorylases were found in both parasites while human fibroblasts had much less of these enzymes. The critical difference between the mutant and the wild type parasites proved to be a 100-fold lower concentration of uracil phosphoribosyltransferase in the fluorodeoxyuridine-resistant mutant. A back mutant of the resistant strain, selected for its ability to use uracil, simultaneously regained uracil phosphoribosyltransferase and sensitivity to fluorodeoxyuridine. This enzymic evidence together with previously published data show that in wild type T. gondii, deoxyuridine is incorporated into nucleic acids through a phosphorolysis to produce uracil which is then converted to uridylic acid by uracil phosphoribosyltransferase.     

Analysis of Drosophila Glucuronyl C5-Epimerase: IMPLICATIONS FOR DEVELOPMENTAL ROLES OF HEPARAN SULFATE SULFATION COMPENSATION AND 2-O-SULFATED GLUCURONIC ACID*

During the biosynthesis of heparan sulfate (HS), glucuronyl C5-epimerase (Hsepi) catalyzes C5-epimerization of glucuronic acid (GlcA), converting it to iduronic acid (IdoA). Because HS 2-O-sulfotransferase (Hs2st) shows a strong substrate preference for IdoA over GlcA, C5-epimerization is required for normal HS sulfation. However, the physiological significance of C5-epimerization remains elusive. To understand the role of Hsepi in development, we isolated Drosophila Hsepi mutants. Homozygous mutants are viable and fertile with only minor morphological defects, including the formation of an ectopic crossvein in the wing, but they have a short lifespan. We propose that two mechanisms contribute to the mild phenotypes of Hsepi mutants: HS sulfation compensation and possible developmental roles of 2-O-sulfated GlcA (GlcA2S). HS disaccharide analysis showed that loss of Hsepi resulted in a significant impairment of 2-O-sulfation and induced compensatory increases in N- and 6-O-sulfation. Simultaneous block of Hsepi and HS 6-O-sulfotransferase (Hs6st) activity disrupted tracheoblast formation, a well established FGF-dependent process. This result suggests that the increase in 6-O-sulfation in Hsepi mutants is critical for the rescue of FGF signaling. We also found that the ectopic crossvein phenotype can be induced by expression of a mutant form of Hs2st with a strong substrate preference for GlcA-containing units, suggesting that this phenotype is associated with abnormal GlcA 2-O-sulfation. Finally, we show that Hsepi formed a complex with Hs2st and Hs6st in S2 cells, raising the possibility that this complex formation contributes to the close functional relationships between these enzymes.     

Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) Is Upregulated in Breast Epithelial–Mesenchymal Transition and Responds to Oxidative Stress

Breast cancer cells that have undergone partial epithelial–mesenchymal transition (EMT) are believed to be more invasive than cells that have completed EMT. To study metabolic reprogramming in different mesenchymal states, we analyzed protein expression following EMT in the breast epithelial cell model D492 with single-shot LFQ supported by a SILAC proteomics approach. The D492 EMT cell model contains three cell lines: the epithelial D492 cells, the mesenchymal D492M cells, and a partial mesenchymal, tumorigenic variant of D492 that overexpresses the oncogene HER2. The analysis classified the D492 and D492M cells as basal-like and D492HER2 as claudin-low. Comparative analysis of D492 and D492M to tumorigenic D492HER2 differentiated metabolic markers of migration from those of invasion. Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) was one of the top dysregulated enzymes in D492HER2. Gene expression analysis of the cancer genome atlas showed that GFPT2 expression was a characteristic of claudin-low breast cancer. siRNA-mediated knockdown of GFPT2 influenced the EMT marker vimentin and both cell growth and invasion in vitro and was accompanied by lowered metabolic flux through the hexosamine biosynthesis pathway (HBP). Knockdown of GFPT2 decreased cystathionine and sulfide:quinone oxidoreductase (SQOR) in the transsulfuration pathway that regulates H₂S production and mitochondrial homeostasis. Moreover, GFPT2 was within the regulation network of insulin and EGF, and its expression was regulated by reduced glutathione (GSH) and suppressed by the oxidative stress regulator GSK3-β. Our results demonstrate that GFPT2 controls growth and invasion in the D492 EMT model, is a marker for oxidative stress, and associated with poor prognosis in claudin-low breast cancer.